19 June 2013
Keywords: Roche, Cellcept, organ transplant drugs, FDA
Article | 17 August 2009
The US Food and Drug Administration has called for the label of Swiss drug major Roche’s Cellcept (mycophenolate mofetil) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 August 2009
18 June 2013
© 2013 thepharmaletter.com